An old vaccine could be a new godsend for coronavirus

Using the oral polio vaccine could prevent or reduce the spread of COVID-19 to immunized individuals.

An old vaccine could be a new godsend for coronavirus

Ultimate control over COVID-19 will be possible only after a large part of the world population becomes immune. This can happen either after a large fraction of the world population gets infected or by prophylactic vaccination. Efforts are underway to accelerate the development of safe and effective vaccines. However, vaccines can be used for mass immunization only if they prove to be safe and effective by thorough clinical evaluation. Given the time this requires, vaccines specific to COVID-19 are likely to remain unavailable for mass immunization during the current pandemic.

In the meantime, we propose an approach to mitigate the SARS-CoV-2 pandemic through the use of existing attenuated live viral vaccines. In particular, oral polio vaccine has been documented to induce protection against a number of viral and bacterial infections. OPV, developed by Albert Sabin, consists of attenuated (weakened) poliovirus and has been used with great success in worldwide efforts to eradicate poliomyelitis.

The importance of innate immunity

In addition to protecting against polio by inducing antibodies that kill the virus, OPV activates other protective mechanisms, including an innate immune system, thus making people resistant to infections caused by other viruses and bacteria. For example, in large scale multicenter clinical trials conducted in the 1970s during outbreaks of seasonal influenza, OPV protected more people from influenza than most flu vaccines do. Furthermore, observational studies in many countries suggested that the hospitalization rate and the overall mortality among children immunized with OPV were consistently lower compared with unimmunized children, even in the absence of poliovirus in communities.

Clinical testing for SARS-CoV-2 in Seattle on April 17, 2020.

Related studies revealed that similar nonspecific protection can be induced by immunizing people with measles vaccine, tuberculosis vaccine (BCG) and some other live attenuated vaccines. These observations suggest that the nonspecific protective effects are a result of boosting innate immunity that is our body’s front-line defense against infectious agents. This protection would last for a period of several weeks or months preventing or reducing the severity of disease in immunized individuals and slowing down the spread of COVID-19.

Lower incidence of COVID-19 in countries using BCG could suggest that the nonspecific protective effects could last much longer. Involvement of innate immunity could be particularly important because there is an indication that it is suppressed by SARS-CoV-2, while immunization with live vaccines is expected to stimulate it.

OPV is a proven safe and inexpensive vaccine routinely used orally in young infants and even newborn babies around the world. Focused analysis and experimentation will be required to ascertain how best to deploy a vaccine conferring high immunity but for a limited duration.

Doctors:Violent trauma will surge amid coronavirus upheaval. We're already seeing it.

In summary, we propose here that trials to test the potential of vaccination with OPV should be quickly explored as a tool to mitigate the pandemic until vaccines specific to SARS-CoV-2 become available. If the outcome of trials proves positive, this approach could be used to control this pandemic as well as subsequent waves of COVID-19, if they occur.

The demonstrated ability of OPV to activate nonspecific immune responses provides a unique opportunity to reset the course of the pandemic. Researchers are testing multiple drugs licensed for other indications to ascertain whether they are effective against SARS-CoV-2. Since strong science already points to the broad nonspecific protective effects of live attenuated vaccines, trials of OPV should now join the drug trails in the quest for effective tools against COVID-19.

Dr. Konstantin Chumakov, associate director for research in the Food and Drug Administration Office of Vaccines Research and Review, is the director of its Global Virus Network Center of Excellence. Dr. Robert Gallo is The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine, and the co-funder and international scientific adviser of the Global Virus Network.


News Related


Trump’s ‘mission accomplished’ moment is premature and deadly. We have not defeated COVID.

Desperate for crowds and adoration, Trump has put his most fervent supporters at risk of getting a deadly disease. Future historians will be astonished. Read more »

NFLPA president JC Tretter says NFL is putting season, players at risk with its coronavirus approach

NFL Players Association president JC Tretter said Tuesday the NFL is putting the 2020 season at risk with its coronavirus approach, calling on the league to better “prioritize player safety.” “Like many other... Read more »

Brazilian President Jair Bolsonaro says he tested positive for the coronavirus

RIO DE JANEIRO (AP) — Brazil’s President Jair Bolsonaro says he has tested positive for COVID-19 after months of downplaying the virus’ severity. Bolsonaro confirmed the test results while wearing a mask and... Read more »

Venice Film Festival forges ahead amid COVID-19 pandemic with reduced lineup

The show will go on for the Venice Film Festival in September, but with a few modifications due to the COVID-19 pandemic. Organizers said Tuesday that they are pushing forward with plans for... Read more »

Amtrak offers buy-one, get-one promotion on its sleeper trains amid COVID-19 — with a catch

Amtrak wants you to have sweet dreams the next time you travel — so much so that it’s sweetening the deal on its sleeper “roomettes.” The rail service is offering a buy-one-get-one-free discount... Read more »

Florida teen treated with hydroxychloroquine at home before dying of COVID-19, report says

FORT MEYERS, Fla. – The family of a 17-year-old Florida girl who died last month from COVID-19 treated her symptoms at home for nearly a week before taking her to a hospital, a... Read more »

Mookie Betts worried MLB coronavirus testing woes could prevent him from ever playing for Dodgers

During nearly four months away from the game, Mookie Betts said he “stayed away from baseball to keep myself sane.” It’s not hard to understand why. The 2018 American League Most Valuable Player... Read more »

Tom Hanks doesn’t get ‘how common sense has somehow been put into question’ with coronavirus

Read more »

Can Gov. DeSantis force Florida schools to reopen amid the coronavirus pandemic? Some school leaders seem doubtful.

PALM BEACH, Fla. — As concern about the state order spread online, some school leaders said: Not so fast. As Florida educators puzzle over how to start the new academic year, Gov. Ron... Read more »

Texas surpasses 200,000 coronavirus cases after 4th of July holiday weekend

AUSTIN, Texas – Texas reached 200,000 total COVID-19 cases Monday, just 17 days after crossing the 100,000 threshold, a figure that took the state nearly four months to hit. The grim milestone came... Read more »